tiprankstipranks
Trending News
More News >
Enorama Pharma AB (SE:ERMA)
:ERMA
Sweden Market
Advertisement

Enorama Pharma AB (ERMA) Cash flow

Compare
0 Followers

Enorama Pharma AB Cash Flow

SE:ERMA's free cash flow for Q2 2025 was kr-7.19M. For the 2025 fiscal year, SE:ERMA's free cash flow was decreased by kr5.65M and operating cash flow was kr-7.19M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
kr -35.70Mkr -41.35Mkr -32.96Mkr -30.16Mkr -23.00M
Investing Cash Flow
kr 0.00kr 0.00kr 0.00kr -1.82Mkr -3.84M
Financing Cash Flow
kr 35.29Mkr 41.86Mkr 25.34Mkr 39.51Mkr 16.96M
End Cash Position
kr 2.08Mkr 6.15Mkr 4.14Mkr 12.20Mkr 4.73M
Free Cash Flow
kr -35.70Mkr -41.35Mkr -32.96Mkr -31.99Mkr -26.83M
Currency in SEK

Enorama Pharma AB Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis